A Systematic Review and Meta-analysis of the Safety and Effectiveness of Remifentanil Intravenous Patient-controlled Analgesia versus Epidural Analgesia on Parturients Requiring Labor Analgesia
Philippine Journal of Anesthesiology · 2026-01 · 31 (1) · 3-15
DOI: 10.4103/pja.pja_6_26 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Philippine Journal of Anesthesiology, online erschienen am 22.07.2026. Verfasst von Bert Ryan Tigley Lim und 1 weiteren Autor:innen. Die Arbeit nennt 19 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
A BSTRACT Introduction: Effective labor analgesia is essential for maternal comfort and optimal delivery outcomes. While epidural analgesia (EA) remains the gold standard for pain relief, remifentanil intravenous patient-controlled analgesia (RPCA) offers a systemic alternative when neuraxial techniques are contraindicated or unavailable. This meta-analysis evaluates the comparative safety and efficacy of RPCA versus EA. Materials and Methods: A systematic review and meta-analysis of controlled trials comparing RPCA and EA during labor was conducted. Primary outcomes included maternal satisfaction, pain scores, and neonatal outcomes (5-min Apgar score, umbilical artery pH). Secondary outcomes were maternal adverse events (hypotension, nausea, vomiting, and pruritus). Pooled effect estimates were calculated as standardized mean differences (SMDs) or risk ratios (RRs) with 95% confidence intervals (CI) using random-or fixed-effects models in Jamovi 2.6.19 and metaanalysisonline.com.
Results
Five studies ( n = 1,983) were included. Maternal satisfaction did not differ significantly between groups (SMD − 0.25, 95% CI − 0.61–0.10). EA provided superior pain relief (SMD 1.07, 95% CI 0.26–1.88). Neonatal outcomes were comparable, with no significant differences in 5-min Apgar scores (SMD − 0.12, 95% CI − 0.38–0.14) or umbilical pH (SMD − 0.02, 95% CI − 0.18–0.15). Adverse event profiles differed: RPCA was associated with higher nausea risk (RR 3.3, 95% CI 1.39–7.87), whereas EA carried a higher pruritus risk (RR 0.54, 95% CI 0.32–0.89). Hypotension and vomiting incidence did not differ significantly.
Conclusion
While EA provides superior pain control, RPCA offers comparable maternal satisfaction and neonatal safety with a distinct side-effect profile. The choice of analgesia should be individualized based on clinical context, patient preference, and risk tolerance.
Zitieren
APA
Lim, B. R. T., & Callangan-Serrano, K. B. (2026). A Systematic Review and Meta-analysis of the Safety and Effectiveness of Remifentanil Intravenous Patient-controlled Analgesia versus Epidural Analgesia on Parturients Requiring Labor Analgesia. Philippine Journal of Anesthesiology, 31(1), 3-15. https://doi.org/10.4103/pja.pja_6_26
Vancouver
Lim BRT, Callangan-Serrano KB. A Systematic Review and Meta-analysis of the Safety and Effectiveness of Remifentanil Intravenous Patient-controlled Analgesia versus Epidural Analgesia on Parturients Requiring Labor Analgesia. Philippine Journal of Anesthesiology. 2026;31(1):3-15. doi:10.4103/pja.pja_6_26
BibTeX
@article{Lim2026,
author = {Lim, Bert Ryan Tigley and Callangan-Serrano, Koneyliz B.},
title = {A Systematic Review and Meta-analysis of the Safety and Effectiveness of Remifentanil Intravenous Patient-controlled Analgesia versus Epidural Analgesia on Parturients Requiring Labor Analgesia},
journal = {Philippine Journal of Anesthesiology},
year = {2026},
volume = {31},
number = {1},
pages = {3--15},
doi = {10.4103/pja.pja_6_26}
}
EUVIMED